Condition: Pulmonary Embolism · Sponsor: Innova Vascular, Inc.
This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ System and the Malibu Aspiration Catheter™ System. These devices are manufactured by Innova Vascular, Inc.
This description comes directly from the study's public registry record.
Sanjay Shrivastava, Ph.D. · 949-295-6040 · ss@innovavascular.com
Always discuss trial participation with your own doctor first.
| Grandview Medical Center | Birmingham, Alabama, United States | Recruiting |
| University of Arizona | Tucson, Arizona, United States | Recruiting |
| University of California Irvine | Irvine, California, United States | Recruiting |
| Memorial Care Long Beach Medical Center | Long Beach, California, United States | Recruiting |
| Mission Hospital Regional Medical Center | Mission Viejo, California, United States | Recruiting |
| St. Joseph Hospital of Orange | Orange, California, United States | Recruiting |
| George Washington University | Washington D.C., District of Columbia, United States | Recruiting |
| Manatee Memorial Hospital | Bradenton, Florida, United States | Recruiting |
| Physicians Regional Medical Center | Naples, Florida, United States | Recruiting |
| AdventHealth Tampa | Tampa, Florida, United States | Completed |
| Rush University Medical Center | Chicago, Illinois, United States | Completed |
| Albany Medical Center | Albany, New York, United States | Completed |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06041594